These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 38454810

  • 1. The role and molecular mechanism of NOP16 in the pathogenesis of nasopharyngeal carcinoma.
    Xiong W, Li D, Ao F, Tu Z, Xiong J.
    Cell Biochem Funct; 2024 Mar; 42(2):e3939. PubMed ID: 38454810
    [Abstract] [Full Text] [Related]

  • 2. FOXD3 inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma through regulation of the PI3K-Akt pathway.
    Xie X, Xiong G, Chen W, Fu H, Li M, Cui X.
    Biochem Cell Biol; 2020 Dec; 98(6):653-660. PubMed ID: 32459973
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
    Zuo WN, Zhu H, Li LP, Jin AY, Wang HQ.
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
    [Abstract] [Full Text] [Related]

  • 5. Saucerneol attenuates nasopharyngeal carcinoma cells proliferation and metastasis through selectively targeting Grp94.
    Cheng Y, Wang Q, Zhang Z, Zhao C, Zhou H, Xu J, Gu Q.
    Phytomedicine; 2022 Jul; 101():154133. PubMed ID: 35504052
    [Abstract] [Full Text] [Related]

  • 6. Circ_0000523 regulates miR-1184/COL1A1/PI3K/Akt pathway to promote nasopharyngeal carcinoma progression.
    Huang P, Li M, Tang Q, Jiang K, Luo Y.
    Apoptosis; 2022 Oct; 27(9-10):751-761. PubMed ID: 35759163
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. LncRNA ZFAS1 promotes proliferation and migration and inhibits apoptosis in nasopharyngeal carcinoma via the PI3K/AKT pathway in vitro.
    Wang X, Jin Q, Wang X, Chen W, Cai Z.
    Cancer Biomark; 2019 Oct; 26(2):171-182. PubMed ID: 31403940
    [Abstract] [Full Text] [Related]

  • 9. Nasopharyngeal carcinoma with non-squamous phenotype may be a variant of nasopharyngeal squamous cell carcinoma after inhibition of EGFR/PI3K/AKT/mTOR pathway.
    Wang J, Shang Y, Wang Y, Li Y, Wang L, Huang S, Lyu X.
    Histol Histopathol; 2024 May; 39(5):647-657. PubMed ID: 37971211
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
    Zhou K, Zhao J, Xu H, Yan X, Liu W, Jiang X, Ren C.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun 28; 47(6):685-697. PubMed ID: 35837768
    [Abstract] [Full Text] [Related]

  • 13. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y, Liu Q, Chen S, Liu Y, Huang Y, Chen P, Li X, Gao G, Xu K, Fan S, Zeng Z, Xiong W, Tan M, Li G, Zhang W.
    FASEB J; 2019 Nov 28; 33(11):11959-11972. PubMed ID: 31408612
    [Abstract] [Full Text] [Related]

  • 14. VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.
    Liang Z, Liu Z, Cheng C, Wang H, Deng X, Liu J, Liu C, Li Y, Fang W.
    Cell Death Dis; 2019 Apr 03; 10(4):305. PubMed ID: 30944308
    [Abstract] [Full Text] [Related]

  • 15. miR-331-3p Inhibits Proliferation and Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Targeting elf4B-PI3K-AKT Pathway.
    Xuefang Z, Ruinian Z, Liji J, Chun Z, Qiaolan Z, Jun J, Yuming C, Junrong H.
    Technol Cancer Res Treat; 2020 Apr 03; 19():1533033819892251. PubMed ID: 31984860
    [Abstract] [Full Text] [Related]

  • 16. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B, Gu Q, Li J.
    Oncol Rep; 2017 Jul 03; 38(1):317-324. PubMed ID: 28586035
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
    Huang Q, Hou S, Zhu X, Liu S.
    World J Surg Oncol; 2020 Feb 03; 18(1):29. PubMed ID: 32013999
    [Abstract] [Full Text] [Related]

  • 18. ADORA1 promotes nasopharyngeal carcinoma cell progression through regulation of PI3K/AKT/GSK-3β/β-catenin signaling.
    Pan S, Liang S, Wang X.
    Life Sci; 2021 Aug 01; 278():119581. PubMed ID: 33961854
    [Abstract] [Full Text] [Related]

  • 19. Chloroform extract from Sophora Tonkinensis Gagnep. inhibit proliferation, migration, invasion and promote apoptosis of nasopharyngeal carcinoma cells by silencing the PI3K/AKT/mTOR signaling pathway.
    ShuoWang, Song Z, Gong X, Ou C, Zhang W, Wang J, Yao C, Qin S, Yan B, Li Q, Wei K, Hou X, Zhou X, Miao J.
    J Ethnopharmacol; 2021 May 10; 271():113879. PubMed ID: 33524509
    [Abstract] [Full Text] [Related]

  • 20. miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN.
    Song L, Chen L, Luan Q, Kong Q.
    J Cell Physiol; 2019 Aug 10; 234(10):17912-17924. PubMed ID: 30834525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.